MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/all.16438

Медицинская библиотека · Allergy · 2024

Genotype-Guided Asthma Treatment Reduces Exacerbations in Children: Meta-Analysis of Two Randomized Control Trials.

Slob Elise M A, Vijverberg Susanne J H, Ruffles Tom, Noij Lieke C E, Biermann Jacqueline, Brouwer Alwin F J, van den Brink Kristel, de Bruin-Kok Annette, Van Ewijk Bart E, Haarman Eric, Hammer Sanne C, Hashimoto Simone, Hogarth Fiona, Jones Christina J, Kamps Arvid W A, Kersten Elin T G, de Kleer Ismé, Lipworth Brian J, Littleford Roberta, Mérelle Marieke, Moeller Alexander, Palmer Colin N A, Pilvinyte Kristina, Rutjes Niels W, van Schaik Ron H N, Smith Helen E, Tavendale Roger, Terheggen-Lagro Suzanne W J, Turner Steve, Twisk Jos W R, Vaessen-Verberne Anja, Verwaal Mariël, de Vries Tjalling, Wesseling Judit, Pijnenburg Mariëlle W, Koppelman Gerard H, Mukhopadhyay Somnath, Maitland-van der Zee Anke H

СтатьяМетаанализПеревод в очереди

Аннотация

BACKGROUND

Long-acting beta2-agonists (LABA) in combination with inhaled corticosteroids (ICS) are commonly used to treat asthma, however, some children lack response to the addition of LABA. This might be partially due to the presence of the Arg16Gly polymorphism, encoded by rs1042713 G>A in the ADRB2 gene. Carrying the A allele (Arg16) at this variant has been associated with an increased risk of exacerbations despite LABA treatment. We investigated whether genotype-guided treatment improved asthma-related outcomes.

METHODS

We conducted an individual participant data meta-analysis of two randomised controlled trials: PUFFIN (Dutch and Swiss 6-18 year-olds) and PACT (English and Scottish 12-18 year-olds). Children with uncontrolled asthma despite ICS who required a step-up in treatment were included. Participants were randomised to genotype-guided treatment or the control group with a follow-up of at least 6 months. Genotype-guided treatment consisted of adding LABA for children with ADRB2 Gly16/Gly16, whilst children with ADRB2 Arg16/Arg16 or Arg16/Gly16 were treated with double dose ICS (PUFFIN) or add-on montelukast (PACT). The primary outcome was a change in asthma control; secondary outcomes included exacerbation rate and time to exacerbation. Repeated measures mixed models and Cox regression were used.

RESULTS

Fifty-nine out of 102 (PUFFIN) and 59 out of 91 (PACT) children had at least one Arg (A allele). Amongst all 193 children, no difference was observed in asthma control between the study groups. However, genotype-guided treatment resulted in lower asthma exacerbation rates (-0.08 (95%CI -0.16 to -0.00, p = 0.04)) compared to the control group.

CONCLUSION

Genotype-guided step-up treatment for children with uncontrolled asthma on ICS may lower asthma exacerbation rates and may be useful for personalising asthma care.

Для цитирования: Slob Elise M A, Vijverberg Susanne J H, Ruffles Tom, Noij Lieke C E, Biermann Jacqueline, Brouwer Alwin F J, van den Brink Kristel, de Bruin-Kok Annette, Van Ewijk Bart E, Haarman Eric, Hammer Sanne C, Hashimoto Simone, Hogarth Fiona, Jones Christina J, Kamps Arvid W A, Kersten Elin T G, de Kleer Ismé, Lipworth Brian J, Littleford Roberta, Mérelle Marieke, Moeller Alexander, Palmer Colin N A, Pilvinyte Kristina, Rutjes Niels W, van Schaik Ron H N, Smith Helen E, Tavendale Roger, Terheggen-Lagro Suzanne W J, Turner Steve, Twisk Jos W R, Vaessen-Verberne Anja, Verwaal Mariël, de Vries Tjalling, Wesseling Judit, Pijnenburg Mariëlle W, Koppelman Gerard H, Mukhopadhyay Somnath, Maitland-van der Zee Anke H. Genotype-Guided Asthma Treatment Reduces Exacerbations in Children: Meta-Analysis of Two Randomized Control Trials.. Allergy. 2024. DOI: 10.1111/all.16438.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.